<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39451673</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2079-6374</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Biosensors</Title><ISOAbbreviation>Biosensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Assessment of Microvascular Function Based on Flowmotion Monitored by the Flow-Mediated Skin Fluorescence Technique.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">459</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/bios14100459</ELocationID><Abstract><AbstractText>This review summarizes studies dedicated to the assessment of microvascular function based on microcirculatory oscillations monitored by the Flow-Mediated Skin Fluorescence (FMSF) technique. Two approaches are presented. The first approach uses oscillatory parameters measured under normoxic conditions, expressed as flowmotion (FM), vasomotion (VM), and the normoxia oscillatory index (NOI). These parameters have been used for the identification of impaired microcirculatory oscillations associated with intense physical exercise, post-COVID syndrome, psychological stress, and erectile dysfunction. The second approach involves characterization of the microcirculatory response to hypoxia based on the measurement of hypoxia sensitivity (HS). The HS parameter is used to characterize microvascular complications in diabetes, such as diabetic kidney disease and diabetic foot ulcers. Based on research conducted by the authors of this review, the FMSF parameter ranges characterizing microvascular function are presented. The diagnostic approach to assessing microvascular function based on flowmotion monitored by the FMSF technique has a wide range of applications and the potential to be integrated into widespread medical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marcinek</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9852-7593</Identifier><AffiliationInfo><Affiliation>Institute of Applied Radiation Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Angionica Ltd., 90-924 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katarzynska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3318-3443</Identifier><AffiliationInfo><Affiliation>Angionica Ltd., 90-924 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cypryk</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Diseases and Diabetology, Medical University of Lodz, 92-213 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Los-Stegienta</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6101-5212</Identifier><AffiliationInfo><Affiliation>Department of Internal Diseases and Diabetology, Medical University of Lodz, 92-213 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slowikowska-Hilczer</LastName><ForeName>Jolanta</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3105-1786</Identifier><AffiliationInfo><Affiliation>Department of Andrology and Reproductive Endocrinology, Medical University of Lodz, 92-213 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walczak-Jedrzejowska</LastName><ForeName>Renata</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4267-5714</Identifier><AffiliationInfo><Affiliation>Department of Andrology and Reproductive Endocrinology, Medical University of Lodz, 92-213 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielinski</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2782-9973</Identifier><AffiliationInfo><Affiliation>Department of Athletics, Strength and Conditioning, Poznan University of Physical Education, 61-871 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebicki</LastName><ForeName>Jerzy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2304-5036</Identifier><AffiliationInfo><Affiliation>Institute of Applied Radiation Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Angionica Ltd., 90-924 Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>POIR.01.01.01-00-0540/15-00</GrantID><Agency>The European Regional Development Fund under the Smart Growth Operational Program</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biosensors (Basel)</MedlineTA><NlmUniqueID>101609191</NlmUniqueID><ISSNLinking>2079-6374</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="Y">Microcirculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="Y">Skin</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FMSF technique</Keyword><Keyword MajorTopicYN="N">flowmotion</Keyword><Keyword MajorTopicYN="N">microcirculation</Keyword><Keyword MajorTopicYN="N">microvascular perfusion</Keyword></KeywordList><CoiStatement>Joanna Katarzynska is employed by Angionica Ltd. Jerzy Gebicki and Andrzej Marcinek are inventors of patents protecting the use of FMSF technology. The remaining authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451673</ArticleId><ArticleId IdType="pmc">PMC11505855</ArticleId><ArticleId IdType="doi">10.3390/bios14100459</ArticleId><ArticleId IdType="pii">bios14100459</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nilsson H., Aalkjaer C. Vasomotion: Mechanisms and Physiological Importance. Mol. Interv. 2003;3:79–89. doi: 10.1124/mi.3.2.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mi.3.2.79</ArticleId><ArticleId IdType="pubmed">14993429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M., Carpi A., Galetta F., Franzoni F., Santoro G. The Investigation of Skin Blood Flowmotion: A New Approach to Study the Microcirculatory Impairment in Vascular Diseases? Biomed. Pharmacother. 2006;60:437–442. doi: 10.1016/j.biopha.2006.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2006.07.012</ArticleId><ArticleId IdType="pubmed">16935461</ArticleId></ArticleIdList></Reference><Reference><Citation>Aalkjær C., Boedtkjer D., Matchkov V. Vasomotion—What Is Currently Thought? Acta Physiol. 2011;202:253–269. doi: 10.1111/j.1748-1716.2011.02320.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.2011.02320.x</ArticleId><ArticleId IdType="pubmed">21518271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Choi J.Y., Kim S.M., Son S.-M., Choi S.-Y., Koo B., Rah C.-S., Nam J.H., Ju M.J., Lee J.S., et al. Vasomotion in Human Arteries and Their Regulations Based on Ion Channel Regulations: 10 Years Study. J. Cell. Physiol. 2023;238:2076–2089. doi: 10.1002/jcp.31067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.31067</ArticleId><ArticleId IdType="pubmed">37672477</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Lucke C., Borgström P., Schmidt-Lucke J.A. Low Frequency Flowmotion/(Vasomotion) during Patho-Physiological Conditions. Life Sci. 2002;71:2713–2728. doi: 10.1016/S0024-3205(02)02110-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(02)02110-0</ArticleId><ArticleId IdType="pubmed">12383879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bari F., Tóth-Szűki V., Domoki F., Kálmán J. Flow Motion Pattern Differences in the Forehead and Forearm Skin: Age-Dependent Alterations Are Not Specific for Alzheimer’s Disease. Microvasc. Res. 2005;70:121–128. doi: 10.1016/j.mvr.2005.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2005.09.001</ArticleId><ArticleId IdType="pubmed">16229865</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M., Matteucci E., Pesce M., Consani C., Galetta F., Giampietro O., Santoro G. Study of Skin Vasomotion in Type 1 Diabetic Patients and of Its Possible Relationship with Clinical and Laboratory Variables. Clin. Hemorheol. Microcirc. 2013;53:357–367. doi: 10.3233/CH-2012-1621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-2012-1621</ArticleId><ArticleId IdType="pubmed">23070199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruning R.S., Kenney W.L., Alexander L.M. Altered Skin Flowmotion in Hypertensive Humans. Microvasc. Res. 2015;97:81–87. doi: 10.1016/j.mvr.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC5466804</ArticleId><ArticleId IdType="pubmed">24418051</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikhonova I.V., Kosyakova N.I., Tankanag A.V., Chemeris N.K. Oscillations of Skin Microvascular Blood Flow in Patients with Asthma. Microcirculation. 2016;23:33–43. doi: 10.1111/micc.12252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/micc.12252</ArticleId><ArticleId IdType="pubmed">26494289</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizeva I., Makovik I., Dunaev A., Krupatkin A., Meglinski I. Analysis of Skin Blood Microflow Oscillations in Patients with Rheumatic Diseases. J. Biomed. Opt. 2017;22:070501. doi: 10.1117/1.JBO.22.7.070501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.22.7.070501</ArticleId><ArticleId IdType="pubmed">28703257</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedanekar T., Kedare R., Sengupta A. Monitoring Tumor Progression by Mapping Skin Microcirculation with Laser Doppler Flowmetry. Lasers Med. Sci. 2019;34:61–77. doi: 10.1007/s10103-018-2600-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-018-2600-z</ArticleId><ArticleId IdType="pubmed">30141135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorelli M., Francia P., Bocchi L., De Bellis A., Anichini R. Assessment of Cutaneous Microcirculation by Laser Doppler Flowmetry in Type 1 Diabetes. Microvasc. Res. 2019;124:91–96. doi: 10.1016/j.mvr.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2019.04.002</ArticleId><ArticleId IdType="pubmed">30959000</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhang Y., Zhang D., Wang W., Xie H., Ruan J., Jin Y., Li T., Li X., Zhao B., et al. Ca2+ Oscillation in Vascular Smooth Muscle Cells Control Myogenic Spontaneous Vasomotion and Counteract Post-Ischemic No-Reflow. Commun. Biol. 2024;7:332. doi: 10.1038/s42003-024-06010-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-024-06010-1</ArticleId><ArticleId IdType="pmc">PMC10942987</ArticleId><ArticleId IdType="pubmed">38491167</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanovska A., Bracic M., Kvernmo H.D. Wavelet Analysis of Oscillations in the Peripheral Blood Circulation Measured by Laser Doppler Technique. IEEE Trans. Biomed. Eng. 1999;46:1230–1239. doi: 10.1109/10.790500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/10.790500</ArticleId><ArticleId IdType="pubmed">10513128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvandal P., Landsverk S.A., Bernjak A., Stefanovska A., Kvernmo H.D., Kirkebøen K.A. Low-Frequency Oscillations of the Laser Doppler Perfusion Signal in Human Skin. Microvasc. Res. 2006;72:120–127. doi: 10.1016/j.mvr.2006.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2006.05.006</ArticleId><ArticleId IdType="pubmed">16854436</ArticleId></ArticleIdList></Reference><Reference><Citation>Holowatz L.A., Thompson-Torgerson C.S., Kenney W.L. The Human Cutaneous Circulation as a Model of Generalized Microvascular Function. J. Appl. Physiol. 2008;105:370–372. doi: 10.1152/japplphysiol.00858.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00858.2007</ArticleId><ArticleId IdType="pubmed">17932300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmann M., Roustit M., Cracowski J.L. Skin Microvascular Endothelial Function as a Biomarker in Cardiovascular Diseases? Pharmacol. Rep. 2015;67:803–810. doi: 10.1016/j.pharep.2015.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharep.2015.05.008</ArticleId><ArticleId IdType="pubmed">26321284</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernjak A., Clarkson P.B.M., McClintock P.V.E., Stefanovska A. Low-Frequency Blood Flow Oscillations in Congestive Heart Failure and after Beta1-Blockade Treatment. Microvasc. Res. 2008;76:224–232. doi: 10.1016/j.mvr.2008.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2008.07.006</ArticleId><ArticleId IdType="pmc">PMC2666799</ArticleId><ArticleId IdType="pubmed">18721820</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough G.F., Kuliga K.Z., Chipperfield A.J. Flow Motion Dynamics of Microvascular Blood Flow and Oxygenation: Evidence of Adaptive Changes in Obesity and Type 2 Diabetes Mellitus/Insulin Resistance. Microcirculation. 2017;24:e12331. doi: 10.1111/micc.12331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/micc.12331</ArticleId><ArticleId IdType="pubmed">27809397</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinek A., Katarzynska J., Sieron L., Skokowski R., Zielinski J., Gebicki J. Non-Invasive Assessment of Vascular Circulation Based on Flow Mediated Skin Fluorescence (FMSF) Biology. 2023;12:385. doi: 10.3390/biology12030385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12030385</ArticleId><ArticleId IdType="pmc">PMC10044925</ArticleId><ArticleId IdType="pubmed">36979077</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinek A., Katarzynska J., Gebicki J. A New Approach to Vascular Screening: Identification of Impaired Vascular Function Using the FMSF Technique. Sensors. 2024;24:1721. doi: 10.3390/s24061721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s24061721</ArticleId><ArticleId IdType="pmc">PMC10976045</ArticleId><ArticleId IdType="pubmed">38543982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebicki J., Katarzynska J., Cholewinski T., Sieron L., Marcinek A. Flowmotion Monitored by Flow Mediated Skin Fluorescence (FMSF): A Tool for Characterization of Microcirculatory Status. Front. Physiol. 2020;11:702. doi: 10.3389/FPHYS.2020.00702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHYS.2020.00702</ArticleId><ArticleId IdType="pmc">PMC7317028</ArticleId><ArticleId IdType="pubmed">32636761</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebicki J., Marcinek A., Zielinski J. Assessment of Microcirculatory Status Based on Stimulation of Myogenic Oscillations by Transient Ischemia: From Health to Disease. Vasc. Health Risk Manag. 2021;17:33–36. doi: 10.2147/VHRM.S292087.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S292087</ArticleId><ArticleId IdType="pmc">PMC7882797</ArticleId><ArticleId IdType="pubmed">33603387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugaj O., Zieliński J., Kusy K., Kantanista A., Wieliński D., Guzik P. The Effect of Exercise on the Skin Content of the Reduced Form of NAD and Its Response to Transient Ischemia and Reperfusion in Highly Trained Athletes. Front. Physiol. 2019;10:600. doi: 10.3389/fphys.2019.00600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00600</ArticleId><ArticleId IdType="pmc">PMC6529559</ArticleId><ArticleId IdType="pubmed">31156467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugaj O., Kusy K., Kantanista A., Korman P., Wieliński D., Zieliński J. The Effect of a 7-Week Training Period on Changes in Skin NADH Fluorescence in Highly Trained Athletes. Appl. Sci. 2020;10:5133. doi: 10.3390/app10155133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app10155133</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson S.A., Graham H.K., Mollan R.A.B., Riddoch C., Sheridan B., Johnston H. Calcium Homeostasis and Exercise. Int. Orthop. 1989;13:69–73. doi: 10.1007/BF00266727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00266727</ArticleId><ArticleId IdType="pubmed">2722319</ArticleId></ArticleIdList></Reference><Reference><Citation>Maïmoun L., Sultan C. Effect of Physical Activity on Calcium Homeostasis and Calciotropic Hormones: A Review. Calcif. Tissue Int. 2009;85:277–286. doi: 10.1007/s00223-009-9277-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-009-9277-z</ArticleId><ArticleId IdType="pubmed">19760298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Cender A., Mordaka R., Zieliński J., Katarzyńska J., Marcinek A., Gebicki J. Chronic Fatigue Associated with Post-COVID Syndrome versus Transient Fatigue Caused by High-Intensity Exercise: Are They Comparable in Terms of Vascular Effects? Vasc. Health Risk Manag. 2022;18:711–719. doi: 10.2147/VHRM.S371468.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S371468</ArticleId><ArticleId IdType="pmc">PMC9464031</ArticleId><ArticleId IdType="pubmed">36097586</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Dyspnea in Post-COVID Syndrome Following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach. Medicina. 2022;58:419. doi: 10.3390/medicina58030419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58030419</ArticleId><ArticleId IdType="pmc">PMC8951558</ArticleId><ArticleId IdType="pubmed">35334595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T., Johnston S., Clarke L., Smith P., Staines D., Marshall-Gradisnik S. Impaired Calcium Mobilization in Natural Killer Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients Is Associated with Transient Receptor Potential Melastatin 3 Ion Channels. Clin. Exp. Immunol. 2017;187:284–293. doi: 10.1111/cei.12882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12882</ArticleId><ArticleId IdType="pmc">PMC5217865</ArticleId><ArticleId IdType="pubmed">27727448</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanowska-Kocejko M., Jędrzejewska A., Braczko A., Stawarska K., Król O., Frańczak M., Harasim G., Smoleński R.T., Hellmann M., Kutryb-Zając B. Red Blood Cell Adenylate Energetics Is Related to Endothelial and Microvascular Function in Long COVID. Biomedicines. 2024;12:554. doi: 10.3390/biomedicines12030554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12030554</ArticleId><ArticleId IdType="pmc">PMC10968064</ArticleId><ArticleId IdType="pubmed">38540167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sara J.D.S., Toya T., Ahmad A., Clark M.M., Gilliam W.P., Lerman L.O., Lerman A. Mental Stress and Its Effects on Vascular Health. Mayo Clin. Proc. 2022;97:951–990. doi: 10.1016/j.mayocp.2022.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2022.02.004</ArticleId><ArticleId IdType="pmc">PMC9058928</ArticleId><ArticleId IdType="pubmed">35512885</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebicki J., Katarzynska J., Marcinek A. Effect of Psychological Stress on Microcirculation Oscillations: Diagnostic Aspects. Vasc. Health Risk Manag. 2023;19:79–82. doi: 10.2147/VHRM.S399082.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S399082</ArticleId><ArticleId IdType="pmc">PMC9926981</ArticleId><ArticleId IdType="pubmed">36798618</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCormack J.K., Armstrong-Carter E.L., Gaudier-Diaz M.M., Meltzer-Brody S., Sloan E.K., Lindquist K.A., Muscatell K.A. β-Adrenergic Contributions to Emotion and Physiology During an Acute Psychosocial Stressor. Psychosom. Med. 2021;83:959–968. doi: 10.1097/PSY.0000000000001009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000001009</ArticleId><ArticleId IdType="pmc">PMC8603364</ArticleId><ArticleId IdType="pubmed">34747583</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotons F.B., Campos J.C., Gonzalez-Correales R., Martín-Morales A., Moncada I., Pomerol J.M. Core Document on Erectile Dysfunction: Key Aspects in the Care of a Patient with Erectile Dysfunction. Int. J. Impot. Res. 2004;16:S26–S39. doi: 10.1038/sj.ijir.3901240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ijir.3901240</ArticleId><ArticleId IdType="pubmed">15496854</ArticleId></ArticleIdList></Reference><Reference><Citation>Montorsi F., Briganti A., Salonia A., Rigatti P., Margonato A., Macchi A., Galli S., Ravagnani P.M., Montorsi P. Erectile Dysfunction Prevalence, Time of Onset and Association with Risk Factors in 300 Consecutive Patients with Acute Chest Pain and Angiographically Documented Coronary Artery Disease. Eur. Urol. 2003;44:360–365. doi: 10.1016/S0302-2838(03)00305-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0302-2838(03)00305-1</ArticleId><ArticleId IdType="pubmed">12932937</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Liao C., Zou Y., Li F., Li T., Zhou Q., Cao Y., Mao X. Erectile Dysfunction and Risk of Clinical Cardiovascular Events: A Meta-Analysis of Seven Cohort Studies. J. Sex. Med. 2010;7:2805–2816. doi: 10.1111/j.1743-6109.2010.01792.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2010.01792.x</ArticleId><ArticleId IdType="pubmed">20367771</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti L., Torlasco C., Lauretta L., Loffi M., Maranta F., Salonia A., Margonato A., Montorsi F., Fragasso G. Erectile Dysfunction in Heart Failure Patients: A Critical Reappraisal. Andrology. 2013;1:177–191. doi: 10.1111/j.2047-2927.2012.00048.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2047-2927.2012.00048.x</ArticleId><ArticleId IdType="pubmed">23339018</ArticleId></ArticleIdList></Reference><Reference><Citation>Yannas D., Frizza F., Vignozzi L., Corona G., Maggi M., Rastrelli G. Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health? J. Clin. Med. 2021;10:2221. doi: 10.3390/jcm10102221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10102221</ArticleId><ArticleId IdType="pmc">PMC8161068</ArticleId><ArticleId IdType="pubmed">34065601</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G., Monami M., Boddi V., Cameron-Smith M., Fisher A.D., De Vita G., Melani C., Balzi D., Sforza A., Forti G., et al. Low Testosterone Is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction. J. Sex. Med. 2010;7:1557–1564. doi: 10.1111/j.1743-6109.2009.01690.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1743-6109.2009.01690.x</ArticleId><ArticleId IdType="pubmed">20102478</ArticleId></ArticleIdList></Reference><Reference><Citation>Colin O., Bergh A., Damber J.-E., Widmark A. Control of Testicular Vasomotion by Testosterone and Tubular Factors in Rats. J. Reprod. Fertil. 1993;97:115–121. doi: 10.1530/jrf.0.0970115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/jrf.0.0970115</ArticleId><ArticleId IdType="pubmed">8464001</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh M., Sharpe R.M., Moffat L., Atanassova N., Saunders P.T.K., Kilter S., Bergh A., Smith L.B. Androgen Action via Testicular Arteriole Smooth Muscle Cells Is Important for Leydig Cell Function, Vasomotion and Testicular Fluid Dynamics. PLoS ONE. 2010;5:e13632. doi: 10.1371/journal.pone.0013632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013632</ArticleId><ArticleId IdType="pmc">PMC2964321</ArticleId><ArticleId IdType="pubmed">21049031</ArticleId></ArticleIdList></Reference><Reference><Citation>Slowikowska-Hilczer J., Walczak-Jedrzejowska R., Adamczewska D., Byczkiewicz P., Marchlewska K., Katarzynska J., Gebicki J. A New Approach to the Assessment of Erectile Dysfunction Based on Vasomotion Monitored by the Flow-Mediated Skin Fluorescence (FMSF) Technique—A Preliminary Study. J. Clin. Med. 2024;13:3210. doi: 10.3390/jcm13113210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13113210</ArticleId><ArticleId IdType="pmc">PMC11173337</ArticleId><ArticleId IdType="pubmed">38892921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J.J., Wen J., Jiang W.H., Lin J., Hong Y., Zhu Y.S. Androgen Actions on Endothelium Functions and Cardiovascular Diseases. J. Geriatr. Cardiol. 2016;13:183–196. doi: 10.11909/j.issn.1671-5411.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2016.02.003</ArticleId><ArticleId IdType="pmc">PMC4854959</ArticleId><ArticleId IdType="pubmed">27168746</ArticleId></ArticleIdList></Reference><Reference><Citation>Er F., Michels G., Brandt M.C., Khan I., Haase H., Eicks M., Lindner M., Hoppe U.C. Impact of Testosterone on Cardiac L-Type Calcium Channels and Ca2+ Sparks: Acute Actions Antagonize Chronic Effects. Cell Calcium. 2007;41:467–477. doi: 10.1016/j.ceca.2006.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2006.09.003</ArticleId><ArticleId IdType="pubmed">17084891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zito S., Nosari G., Pigoni A., Moltrasio C., Delvecchio G. Association between Testosterone Levels and Mood Disorders: A Minireview. J. Affect. Disord. 2023;330:48–56. doi: 10.1016/j.jad.2023.02.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.02.108</ArticleId><ArticleId IdType="pubmed">36841309</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wei Q., Guo C., Dong G., Liu Y., Tang C., Dong Z. Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease. Int. J. Mol. Sci. 2017;18:950. doi: 10.3390/ijms18050950.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18050950</ArticleId><ArticleId IdType="pmc">PMC5454863</ArticleId><ArticleId IdType="pubmed">28468297</ArticleId></ArticleIdList></Reference><Reference><Citation>Catrina S.-B., Zheng X. Disturbed Hypoxic Responses as a Pathogenic Mechanism of Diabetic Foot Ulcers. Diabetes Metab. Res. Rev. 2016;32:179–185. doi: 10.1002/dmrr.2742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.2742</ArticleId><ArticleId IdType="pubmed">26453314</ArticleId></ArticleIdList></Reference><Reference><Citation>Catrina S.B., Zheng X. Hypoxia and Hypoxia-Inducible Factors in Diabetes and Its Complications. Diabetologia. 2021;64:709–716. doi: 10.1007/s00125-021-05380-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-021-05380-z</ArticleId><ArticleId IdType="pmc">PMC7940280</ArticleId><ArticleId IdType="pubmed">33496820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dei Cas A., Gnudi L. VEGF and Angiopoietins in Diabetic Glomerulopathy: How Far for a New Treatment? Metabolism. 2012;61:1666–1673. doi: 10.1016/j.metabol.2012.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2012.04.004</ArticleId><ArticleId IdType="pubmed">22554833</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangarajah H., Yao D., Chang E.I., Shi Y., Jazayeri L., Vial I.N., Galiano R.D., Du X.-L., Grogan R., Galvez M.G., et al. The Molecular Basis for Impaired Hypoxia-Induced VEGF Expression in Diabetic Tissues. Proc. Natl. Acad. Sci. USA. 2009;106:13505–13510. doi: 10.1073/pnas.0906670106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906670106</ArticleId><ArticleId IdType="pmc">PMC2726398</ArticleId><ArticleId IdType="pubmed">19666581</ArticleId></ArticleIdList></Reference><Reference><Citation>Los-Stegienta A., Borkowska A., Cypryk K. Assessment of Microvascular Function Using a Novel Technique Flow Mediated Skin Fluorescence (FMSF) in Patients with Diabetic Kidney Disease: A Preliminary Study. Microvasc. Res. 2022;144:104417. doi: 10.1016/j.mvr.2022.104417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2022.104417</ArticleId><ArticleId IdType="pubmed">35931125</ArticleId></ArticleIdList></Reference><Reference><Citation>Los-Stegienta A., Katarzynska J., Borkowska A., Marcinek A., Cypryk K., Gebicki J. Differentiation of Diabetic Foot Ulcers Based on Stimulation of Myogenic Oscillations by Transient Ischemia. Vasc. Health Risk Manag. 2021;17:145–152. doi: 10.2147/VHRM.S307366.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S307366</ArticleId><ArticleId IdType="pmc">PMC8064676</ArticleId><ArticleId IdType="pubmed">33907408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>